USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke INTRABIO wurde als Wortmarke am 14.02.2018 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".
Markeninhaber
170 Finchley Road; London NW3 6BP
Waren und Dienstleistungen
5
Pharmaceutical preparations; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; drugs for medical purposes; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; reagents for use in medical genetic testing; diagnostic reagents for medical laboratory use; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; amino acid preparations for medical purposes; amino acid preparations for pharmaceutical use
42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; scientific and technological services and research in the field of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; industrial analysis and research services related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy, design and development of computer hardware and software related to assays; clinical trials; conducting clinical trials for pharmaceutical products; conducting clinical trials for neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; medical laboratories for research related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; providing information about the results of clinical trials for pharmaceutical products; clinical research; medical laboratories; research relating to molecular sciences; medical research; genetic research; research in the field of gene therapy; biopharmaceutical research for development of targeted therapies for use in the treatment of carcinomas and neurodegenerative diseases; scientific, biochemical, research and development services in the field of neurodegenerative diseases; providing scientific information in the field of medical disorders and their treatment; pharmaceutical drug development services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1379232153